Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells

Genes Chromosomes and Cancer

Volumn 41, Issue 3, 2004, Pages 203-213

  MacGrogan, Donal ^a   Kalakonda, Nagesh ^a   Alvarez, Sara ^a,c   Scandura, Joseph M ^a   Boccuni, Piernicola ^a   Johansson, Bertil ^b   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DROSOPHILA PROTEIN; MESSENGER RNA; NUCLEOTIDE; REPRESSOR PROTEIN; SCM PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; BMI1 GENE; BONE MARROW; CARCINOGENESIS; CELL POPULATION; CHROMOSOME 20Q; CONTROLLED STUDY; DL3MBT GENE; EXON; GENE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE LOCATION; GENE STRUCTURE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTRON; L3MBTL GENE; LEUKEMIA CELL LINE; LYMPHOID CELL; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; NUCLEOTIDE SEQUENCE; PCG GENE; PRIORITY JOURNAL; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD34; BONE MARROW CELLS; CELL LINE, TUMOR; DNA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, COMPLEMENTARY; EXONS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; LOSS OF HETEROZYGOSITY; MUTATION; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ANALYSIS, DNA;

EID: 4644281190     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20087     Document Type: Article

References (46)

1. Akasaka T, van Lohuizen M, van der Lugt N, Mizutani-Koseki Y, Kanno M, Taniguchi M, Vidai M, Alkema M, Berns A, Koseki H. 2001. Mice doubly deficient for the Polycomb group genes Me118 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development 128:158-1597.
2. Asimakopoulos FA, Green AR. 1996. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol 95:219-226.
3. Ayton PM, Cleary ML. 2001. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20:5695-5707.
4. Bea S, Tort F, Pinyol M, Puig X, Hernandez L, Hernandez S, Fernandez PL, van Lohuizen M, Colomer D, Campo E. 2001. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 61:2409-2412.
5. Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, Champion KM, Li J, Whittaker P, Stavrides G, Hunt AR, Huntly BJ, Campbell LJ, Bentley DR, Deloukas P, Green AR. 2000. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 19:3902-3913.
6. Berger J, Kurahashi H, Takihara Y, Shimada K, Brock HW, Randazzo F. 1999. The human homolog of Sex comb on midleg (SCMH1) maps to chromosome 1 p34. Gene 237:185-191.
7. Boccuni P, MacGrogan D, Scandura JM, Nimer SD. 2003. The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6). J Biol Chem 278:15412-15420.
8. Bornemanh D, Miller E, Simon J. 1996. The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein. Development 122:1621-1630.
9. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Heiin K. 2003. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22:5323-5335.
10. De Vos J, Thykjaer T, Tarte K, Ensslen M, Raynaud P, Requirand G, Pellet F. Pantesco V, Reme T, Jourdan M, Rossi JF, Orntoft T, Klein B. 2002. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 21:6848-6857.
11. Gateff E, Loffler T, Wismar J. 1993. A temperature-sensitive brain tumor suppressor mutation of Drosophila melanogaster: developmental studies and molecular localization of the gene. Mech Dev 41:15-31.
12. Hodgson JG, Chin K, Collins C, Gray JW. 2003. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78:337-345.
13. Jacobs JJ, van Lohuizen M. 2002. Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta 1602:151-161.
14. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. 1999. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13:2678-2690.
15. Kennison JA. 1995. The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 29:289-303.
16. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM. 2003. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Nad Acad Sci USA 100:11606-11611.
17. Knudson AG. 2001. Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157-162.
18. Koga H, Matsui S, Hirota T, Takebayashi S, Okumura K, Saya H. 1999. A human homolog of Drosophila lethal(3)malignant brain tumor (1(3)mbt) protein associates with condensed mitotic chromosomes. Oncogene 18:3799-3809.
19. Kyba M, Brock HW. 1998. The SAM domain of polyhomeotic, RAE28, and scm mediates specific interactions through conserved residues. Dev Genet 22:74-84.
20. Lessard J, Baban S, Sauvageau G. 1998. Stage-specific expression of polycomb group genes in human bone marrow cells. Blood 91: 1216-1224.
21. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S. 2004. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428:337-341.
22. MacGrogan D, Alvarez S, DeBlasio T, Jhanwar SC, Nimer SD. 2001. Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines. Oncogene 20:4150-4160.
23. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP. 2003. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28:69-74.
24. Mitelman F, Johansson B, Mertens F. 2004. Mitelman Database of Chromosome Aberrations in Cancer. Available from: http://cgap.nci.nih.gov/Chromosomes/ Mitelman
25. Montini E, Buchner G, Spalluto C, Andolfi G, Caruso A, den Dunnen JT, Trump D, Rocchi M, Ballabio A, Franco B. 1999. Identification of SCML2, a second human gene homologous to the Drosophila sex comb on midleg (Scm): a new gene cluster on Xp22. Genomics 58:65-72.
26. Mori N, Morosetti R, Lee S, Spira S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. 1997. Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood 90:2010-2014.
27. Pirrotta V. 1997. PcG complexes and chromatin silencing. Curr Opin Genet Dev 7:249-258.
28. Raaphorst FM, Otte AP, Meijer CJ. 2001. Polycomb-group genes as regulators of mammalian lymphopoiesis. Trends Immunol 22: 682-690.
29. Saha V, Young BD, Freemont PS. 1998. Translocations, fusion genes, and acute leukemia. J Cell Biochem Suppl 30-31:264-276.
30. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
31. Saurin AJ, Shao Z, Erdjument-Bromage H, Tempst P, Kingston RE. 2001. A Drosophila Polycomb group complex includes Zeste and dTAFII proteins. Nature 412:655-660.
32. Schumacher A, Magnuson T. 1997. Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond. Trends Genet 13:167-170.
33. Sellers WR, Loda M. 2002. The EZH2 polycomb transcriptional represser - a marker or mover of metastatic prostate cancer? Cancer Cell 2:349-350.
34. Su IH, Basavaraj A, Krutchinsky AN, Hubert O, Ullrich A, Chait BT, Tarakhovsky A. 2003. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 4:124-131.
35. Tokimasa S, Ohta H, Sawada A, Matsuda Y, Kim JY, Nishiguchi S, Hara J, Takihara Y. 2001. Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage. Exp Hematol 29:93-103.
36. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M, van Lohuizen M. 1994. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8:757-769.
37. van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ. 2001. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97:3896-3901.
38. van Lohuizen M. 1999. The trithorax-group and polycomb-group chromatin modifiers: implications for disease. Curr Opin Genet Dev 9:355-361.
39. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629.
40. Visser HP, Gunster MJ, Kluin-Nelemans HC, Manders EM, Raaphorst FM, Meijer CJ, Willemze R, Otte AP. 2001. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 112:950-958.
41. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC. 2001. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84:1372-1376.
42. Wang PW, Eisenbart JD, Cordes SP, Barsh GS, Stoffel M, Le Beau MM. 1999. Human KRML (MAFB): cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. Genomics 59:275-281.
43. Wang PW, Eisenbart JD, Espinosa R 3rd, Davis EM, Larson RA, Le Beau MM. 2000. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map. Genomics 67:28-39.
44. Wang WK, Tereshko V, Boccuni P, MacGrogan D, Nimer SD, Patel DJ. 2003. Malignant brain tumor repeats: a three-leaved propeller architecture with ligand/peptide binding pockets. Structure (Camb) 11:775-789.
45. Wismar J. 2001. Molecular characterization of h-I(3)mbt-like: a new member of the human mbt family. FEES Lett 507:119-121.
46. Wismar J, Loffler T, Habtemichael N, Vef O, Geissen M, Zirwes R, Altmeyer W, Sass H, Gateff E. 1995. The Drosophila melanogaster tumor suppressor gene lethal(3)malignant brain tumor encodes a proline-rich protein with a novel zinc finger. Mech Dev 53:141-154.